Pfizer Limited (NSE:PFIZER)
4,826.80
+25.50 (0.53%)
Jul 31, 2026, 3:29 PM IST
Pfizer Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Pfizer stock has a consensus rating of "Strong Buy" and an average price target of ₹6,659. The average 1-year stock price forecast is 37.95% higher than the current stock price, while the lowest is ₹5,815 (+20.47%) and the highest is ₹7,500 (+55.38%).
Price Target: ₹6,659 (+37.95%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Feb 10, 2026.
Analyst Ratings
The average analyst rating for Pfizer stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst ICICI Securities No rating | ICICI Securities | Buy Maintains ₹6,030 | Buy | Maintains | ₹6,030 | +24.93% | Feb 10, 2026 |
Financial Forecast
Revenue This Year
27.38B
from 25.20B
Increased by 8.65%
Revenue Next Year
29.85B
from 27.38B
Increased by 9.03%
EPS This Year
184.35
from 165.88
Increased by 11.13%
EPS Next Year
207.45
from 184.35
Increased by 12.53%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.